The Court of Common Pleas in Philadelphia has delayed trial deadlines in the cases over Yaz/Yasmin/Beyaz birth control for another 60 days, extending them until July 9.
Judge Sandra Moss announced the latest extension on April 25, 2012. She’d previously announced a delay on March 9, 2012. This will allow the parties in the case more time to negotiate.
Lopez McHugh is representing multiple plaintiffs against Bayer Healthcare, manufacturer of the birth control pills Yasmin, Yaz, Beyaz, and Ocella. The plaintiffs’ claim, supported by a number of studies, is that Bayer failed to warn users that the company’s birth control pills cause an increased risk of blood clots.
The Yaz group of drugs contains a compound created by Bayer called drospirenone, a synthetic progestogen that may elevate the levels of potassium in the body. The most common serious injuries from these drugs are blood clots, pulmonary embolisms, strokes, or gallbladder removals.
The following birth control pills contain drospirenone and all have a higher risk of injury: Beyaz, Gianvi, Loryna, Ocella, Safyral, Syeda, Yasmin, Yaz, and Zarah.
